AMRX
Amneal Pharmaceuticals (AMRX) Investor Questions
Review Amneal Pharmaceuticals (AMRX) faq with company data, supporting context and links to related investor research.
Research record updated: . Individual measures may refer to different reporting periods.
- Company
- Amneal Pharmaceuticals
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Overall BTI score
- 51
- Annual revenue
- $3.02B
- Annual net income
- $72.06M
- Annual free cash flow
- $269.93M
Amneal Pharmaceuticals (AMRX) Investor Questions research
Amneal Pharmaceuticals trades under the ticker AMRX. The company is classified in the Healthcare sector and the Drug Manufacturers - Specialty & Generic industry.
Investors commonly review AMRX through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. Use the financial statements to check whether reported profit is supported by cash generation.